Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07187869
What this trial is testing

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00003551
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Emory University
Not applicableNo Longer AvailableNCT06090331
What this trial is testing

89Zr-DFO-girentuximab Expanded Access Program (EAP)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Testing effectiveness (Phase 2)WithdrawnNCT02763761
What this trial is testing

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Who this might be right for
Renal Cell CarcinomaMelanomaLung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT06889649
What this trial is testing

SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC

Who this might be right for
Radiation TherapyTargeted TherapyImmunotherapy+1 more
Peking University First Hospital 30
Not applicableWithdrawnNCT07624578
What this trial is testing

Evaluation of 68Ga-PSMA PET-CT in the Initial Staging of Advanced Renal Cell Carcinomas - A Prospective, Multicentre, Open-label Study

Who this might be right for
Kidney Cancers
Assistance Publique Hopitaux De Marseille
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Large-scale testing (Phase 3)Looking for participantsNCT06349668
What this trial is testing

Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

Who this might be right for
Other Specified Disorders of Kidney and UreterBenign Neoplasm of UreterCalculus of Kidney and Ureter+5 more
Hans Bahlmann 220
Early research (Phase 1)Study completedNCT02386826
What this trial is testing

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGliosarcomaColorectal Cancer+1 more
SCRI Development Innovations, LLC 65
Testing effectiveness (Phase 2)Study completedNCT02724878
What this trial is testing

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-Clear Cell Kidney Cancer
Dana-Farber Cancer Institute 65
Large-scale testing (Phase 3)Study completedNCT00111020
What this trial is testing

Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 2,567
Testing effectiveness (Phase 2)UnknownNCT05879497
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 40
Large-scale testing (Phase 3)Study completedNCT00375674
What this trial is testing

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Who this might be right for
Kidney Neoplasms
Pfizer 674
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Not applicableUnknownNCT04666220
What this trial is testing

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

Who this might be right for
Renal Cell CarcinomaAdrenal Carcinoma
Humanitas Clinical and Research Center 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546
What this trial is testing

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 69
Not applicableStudy completedNCT05070637
What this trial is testing

Circulating Tumor Cell Reducing No-touch Nephrectomy

Who this might be right for
Renal Cell CarcinomaCirculating Tumor Cell
Hospital de Santa Maria, Portugal 44
Testing effectiveness (Phase 2)UnknownNCT04631731
What this trial is testing

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

Who this might be right for
Lung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more
Western Sydney Local Health District 200
Not applicableWithdrawnNCT02307474
What this trial is testing

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma
Case Comprehensive Cancer Center
Next Page